Showing results (741-750 of 152,529) with videos related to
Sort By:
Pageof 15,253
Okajimas Folia Anatomica Japonica|December 8, 2017
Changes in topographical relation between the ductus arteriosus and left subclavian artery in human embryos: a study using serial sectionsHiroshi Abe, Masahito Yamamoto, Ryoji Suzuki, et al.Journal of Prosthodontic Research|June 30, 2016
Mandibular movement during sleep bruxism associated with current tooth attritionKazuo Okura, Shuji Shigemoto, Yoshitaka Suzuki, et al.Hepatology (Baltimore, Md.)|November 5, 2020
Contrast-Enhanced Ultrasonography-Based Hepatic Perfusion for Early Prediction of Prognosis in Acute Liver FailureHidekatsu Kuroda, Tamami Abe, Yudai Fujiwara, et al.The FEBS Journal|January 4, 2023
A tyrosine-based YXXΦ motif regulates the degradation of aquaporin-4 via both lysosomal and proteasomal pathways and is functionally inhibited by a 10-amino-acid sequence within its C-terminusYingqi Wang, Ryosuke Suzuki, Atsushi Fujii, et al.Journal of Asthma and Allergy|December 31, 2020
Annual Fractional Exhaled Nitric Oxide Measurements and Exacerbations in Severe AsthmaYuki Abe, Masaru Suzuki, Hirokazu Kimura, et al.AJNR. American Journal of Neuroradiology|April 5, 2008
Patient skin dose during neuroembolization by multiple-point measurement using a radiosensitive indicatorS Suzuki, S Furui, Y Matsumaru, et al.Inorganic Chemistry|April 3, 2008
Spectral evidence and DFT calculations on the formation of Bis(2,2'-bipyridine)platinum(II)-N-base adductsYuji Kawanishi, Takashi Funaki, Tetsuo Yatabe, et al.Nihon Gan Chiryo Gakkai Shi|August 20, 1989
[A study of the number of binding sites of estrogen receptors as a malignancy factor in primary breast cancer]M Nihei, A Tsuchiya, I Kimijima, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 26, 2012
[Increased level of KL-6 in a BJP-λ-type multiple myeloma patient with poor prognosis]Yasunori Nakagawa, Hiromitsu Iizuka, Sayuri Nishiyama, et al.Therapeutic Advances in Cardiovascular Disease|July 4, 2012
Eplerenone, an aldosterone blocker, is more effective in reducing blood pressure in patients with, than without, metabolic syndromeHiromichi Suzuki, Hiroshi Shuto, Chizuru Shuto, et al.Pageof 15,253